• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Antares Pharma Inc. (ATRS)

    -NasdaqCM
    2.61 Down 0.04(1.51%) Feb 27, 4:00PM EST
    |After Hours : 2.65 Up 0.04 (1.49%) Feb 27, 6:08PM EST
    Add to Portfolio
    Prev Close:2.65
    Open:2.65
    Bid:2.62 x 200
    Ask:N/A
    1y Target Est:5.30
    Beta:2
    Earnings Date:Mar 11 - Mar 16 (Est.)
    Day's Range:2.60 - 2.67
    52wk Range:1.82 - 4.68
    Volume:402,881
    Avg Vol (3m):936,649
    Market Cap:343.70M
    P/E (ttm):N/A
    EPS (ttm):-0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ATRS

    Comparison

    Symbol% ChgMkt Cap
    ATRSDown 1.51%343.70M
    BDXDown 1.23%28.31B
    BJCTDown 10.00%N/A

    Key Statistics

    Forward P/E (1 yr):261.00
    P/S (ttm):15.28
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.24
    Quarterly EPS Est (Dec-14) :-0.05
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):-0.14

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback